Sterrenburg; Jan Gerard
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sterrenburg; Jan Gerard.The latest application filed is for "4-imidazopyridazin-1-yl-benzamides as btk inhibitors".
- Sterrenburg; Jan Gerard - Oss NL
- Sterrenburg; Jan Gerard - Renkum NL
- Sterrenburg; Jan Gerard - TE Renkum NL
| Patent | Date |
|---|---|
| (5,6-dihydro)pyrimido[4,5-E]indolizines Grant RE48,974 - De Man , et al. March 15, 2 | 2022-03-15 |
| 4-imidazopyridazin-1-yl-benzamides As Btk Inhibitors App 20210230166 - Barf; Tjeerd A. ; et al. | 2021-07-29 |
| 3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenase Grant 11,053,230 - De Man , et al. July 6, 2 | 2021-07-06 |
| 4-imidazopyridazin-1-yl-benzamides as Btk inhibitors Grant 10,934,296 - Barf , et al. March 2, 2 | 2021-03-02 |
| Inhibitors of tryptophan 2,3-dioxygenase Grant 10,689,343 - De Man , et al. | 2020-06-23 |
| 3-hydroxy-imidazolidin-4-one Compounds As Inhibitors Of Indoleamine 2,3-dioxygenase App 20200181128 - De Man; Adrianus Petrus Antonius ; et al. | 2020-06-11 |
| Inhibitors of indoleamine 2,3-dioxygenase Grant 10,494,360 - De Man , et al. De | 2019-12-03 |
| Intibtors Of Tryptophan 2,3-dioxygenase App 20190315688 - De Man; Adrianus Petrus Antonius ; et al. | 2019-10-17 |
| 4-imidazopyridazin-1-yl-benzamides As Btk Inhibitors App 20190276456 - Barf; Tjeerd A. ; et al. | 2019-09-12 |
| 4-imidazopyridazin-1-yl-benzamides as BTK inhibitors Grant 10,239,883 - Barf , et al. | 2019-03-26 |
| Inhibitors Of Indoleamine 2,3-dioxygenase App 20190055213 - DE MAN; Adrianus Petrus Antonius ; et al. | 2019-02-21 |
| 4-imidazopyridazin-1-yl-benzamides As Btk Inhibitors App 20180179212 - Barf; Tjeerd A. ; et al. | 2018-06-28 |
| (5,6-dihydro)pyrimido[4,5-E]indolizines Grant 9,856,258 - De Man , et al. January 2, 2 | 2018-01-02 |
| 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as BtK inhibitors Grant 9,790,226 - Barf , et al. October 17, 2 | 2017-10-17 |
| 4-imidazopyridazin-1-yl-benzamides as Btk inhibitors Grant 9,758,524 - Barf , et al. September 12, 2 | 2017-09-12 |
| BTK Inhibitors Grant 9,718,828 - De Man , et al. August 1, 2 | 2017-08-01 |
| (5,6-dihydro)pyrimido[4,5-e]indolizines App 20170096432 - DE MAN; Adrianus Petrus Antonius ; et al. | 2017-04-06 |
| Btk Inhibitors App 20170008899 - DE MAN; ADRIANUS PETRUS ANTONIUS ; et al. | 2017-01-12 |
| 4-imidazopyridazin-1-yl-benzamides And 4-imidazotriazin-1-yl-benzamides As Btk Inhibitors App 20160159810 - Barf; Tjeerd A. ; et al. | 2016-06-09 |
| 4-imidazopyridazin-1-yl-benzamides And 4-imidazotriazin-1-yl-benzamides As Btk Inhibitors App 20160151364 - Barf; Tjeerd A. ; et al. | 2016-06-02 |
| 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as Btk inhibitors Grant 9,290,504 - Barf , et al. March 22, 2 | 2016-03-22 |
| Btk Inhibitors App 20140221333 - De Man; Adrianus Petrus Antonius ; et al. | 2014-08-07 |
| 4-imidazopyridazin-1-yl-benzamides And 4-imidazotriazin-1-yl-benzamides Btk Inhibitors App 20140155406 - Man; Petrus Antonius De Adrianus ; et al. | 2014-06-05 |
| 4-imidazopyridazin-1-yl-benzamides And 4-imidazotriazin-1-yl-benzamides As Btk Inhibitors App 20140155385 - Barf; Tjeerd A. ; et al. | 2014-06-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 